
Insiders Updates
Potential Price Increase for Aldeyra Therapeutics Inc (ALDX) After Recent Insider Activity
In a filing, Aldeyra Therapeutics Inc revealed its Chief Development Officer Machatha Stephen unloaded Company’s shares for reported $75975.0 on